Category: News

TriReme Reports Results for Clinical Trial of Chocolate PTA Device at 10th Annual Leipzig Conference

PLEASANTON Calif. and SINGAPORE, February 6, 2014 /PRNewswire/ — Interim results from The CHOCOLATE® BAR Registry conducted in the US demonstrate that use of the

Amaranth Medical Announces Investment from Boston Scientific

MOUNTAIN VIEW, Calif. (January 14, 2014) – Amaranth Medical, a privately held medical device company, today announced the closing of an equity investment by Boston

Ivantis Completes $46.5 MM Financing;Receives Approval to Expand US Trial for Novel Glaucoma Device

One of the largest medical device financings of the past year in the US; funds will support multiple clinical trials, including recently expanded US pivotal

Forma, Boehringer Further Collaborate to Modulate Protein-Protein Interaction for Cancer Treatment

WATERTOWN, Mass. – January 9, 2014 – FORMA Therapeutics announced today the achievement of several discovery milestones in their alliance with Boehringer Ingelheim (BI) for

Revance, Dicerna ring out an IPO boom year with $155M in pitches

A pair of small biotechs with big dreams made it under the wire to end 2013 with the last IPO pitches of the year. Revance Therapeutics

AnQuanBao appointed as one of the first partners for China Info. Security Vulnerability Database

【2013 年 12 月 20 日】在近日召开的第六届漏洞分析不风险评估大会上,中国信息 安全测评中心举行了中国国家信息安全漏洞库(CNNVD)技术支撑单位的授牌仪式不特聘 与家证书颁发仪式。网站安全与家安全宝成为首批国家漏洞库支撑单位,并领取了授权牌。

Ooyala receives $43M investment from Telstra to accelerate adoption of its market-leading video

MOUNTAIN VIEW, Calif. (December 11, 2013) — Ooyala, the leading innovator in video streaming, analytics and monetization, today announced it received a USD $43 million

MerLion Pharmaceuticals Announces Initiation of first Phase II Clinical Study with Finafloxacin

Singapore, 11th December 2012 – MerLion Pharmaceuticals (MerLion) announced today that it has initiated the first Phase II clinical trial using intravenous (iv) and oral

FDA clears new continuous blood pressure technology from Sotera Wireless

SAN DIEGO – October 10, 2013 – Sotera® Wireless, Inc. today announced the U.S. Food and Drug Administration has cleared the Company’s patented continuous non-invasive

Amaranth Medical Raises $20M in series B to support development of the Fortititude Bioresorbable

Singapore – October 8, 2013 – Amaranth Medical, a privately-held medical device company, announced the closing of a US $20 million Series B financing led